PUBLISHER: The Business Research Company | PRODUCT CODE: 1948600
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948600
Vaccine delivery devices are mechanisms or systems devised to safely and efficiently administer vaccines to individuals. Engineered with precision, these tools guarantee precise dosage, accurate delivery, and minimal discomfort for the recipient. Their significance in public health endeavors lies in their ability to facilitate the distribution and application of vaccines, thereby thwarting the spread of infectious diseases.
The primary categories of vaccine delivery devices comprise needle-free injection systems, oral delivery systems, nasal delivery systems, jet injectors, microneedle patches, and microinjectors. Needle-free injection systems are medical tools designed to administer medication into the skin without employing a conventional needle. They facilitate various routes of administration, including intradermal, intramuscular, and subcutaneous vaccination, and are utilized by a range of end-users, including hospitals and clinics.
Tariffs are impacting the vaccine delivery devices market by increasing costs of imported medical-grade plastics, precision springs, microfabricated components, electronic control units, and sterile packaging materials used in advanced delivery systems. Manufacturers and healthcare systems in North America and Europe are most affected due to reliance on globally sourced components, while Asia-Pacific faces higher production costs for export-oriented devices. These tariffs are contributing to higher device procurement costs and slower rollout timelines in public health programs. However, they are also encouraging localized manufacturing, regional supply chain strengthening, and domestic innovation in cost-effective vaccine delivery technologies.
The vaccine delivery devices market research report is one of a series of new reports from The Business Research Company that provides vaccine delivery devices market statistics, including vaccine delivery devices industry global market size, regional shares, competitors with a vaccine delivery devices market share, detailed vaccine delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the vaccine delivery devices industry. This vaccine delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vaccine delivery devices market size has grown rapidly in recent years. It will grow from $7.01 billion in 2025 to $7.72 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to expansion of national immunization initiatives, increasing global vaccine production capacity, rising prevalence of infectious diseases, improvements in cold-chain logistics, widespread use of conventional syringe-based delivery.
The vaccine delivery devices market size is expected to see strong growth in the next few years. It will grow to $10.9 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing development of next-generation vaccines, rising demand for self-administration devices, expansion of pandemic preparedness programs, growing investments in vaccine accessibility technologies, increased focus on dose accuracy and compliance. Major trends in the forecast period include increasing adoption of needle-free injection technologies, rising demand for microneedle patch delivery systems, growing use of alternative vaccine administration routes, expansion of mass immunization programs, enhanced focus on patient comfort and safety.
The growing prevalence of infectious diseases is expected to drive the growth of the vaccine delivery devices market. Infectious diseases are caused by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, and can spread between individuals, animals, or via contaminated environments. Factors such as rapid urbanization, increased international travel, climate-driven ecological changes, and rising population density contribute to the spread of these pathogens. Vaccine delivery devices play a critical role in public health by enabling safe and efficient vaccine administration, boosting community immunity, and limiting the transmission of infectious agents. For instance, in November 2024, the World Health Organization (WHO), a Switzerland-based specialized UN agency for global public health, reported an estimated 10.3 million measles cases worldwide in 2023, marking a 20% increase compared to 2022. Therefore, the rising prevalence of infectious diseases is driving the growth of the vaccine delivery devices market.
Major companies in the vaccine delivery devices market are focusing on developing advanced technologies, such as innovative intradermal delivery systems, to improve vaccine effectiveness and reduce wastage. An intradermal delivery system is designed to administer vaccines directly into the dermal layer, which is rich in immune cells, thereby eliciting stronger immune responses while using smaller vaccine volumes. For instance, in July 2025, Terumo Corporation, a Japan-based medical technology company, launched the Immucise Intradermal Injection System, a vertical-puncture device featuring a 33G needle for precise intradermal administration. This system ensures consistent wheal formation with minimal leakage, improves the accuracy of intradermal injections compared to the traditional Mantoux technique, and allows significant reductions in vaccine dosage. By enhancing immunogenicity, optimizing resource utilization, and streamlining procedures, the Immucise system advances vaccination efficiency and operational effectiveness in healthcare settings.
In March 2024, Sharps Technology Inc., a US-based medical device company, partnered with Roncadelle Operations to enhance high-precision syringe manufacturing and expand global supply capacity for next-generation vaccine delivery solutions. This collaboration aims to advance the development of next-generation prefillable syringe systems and custom auto-injector components while strengthening domestic manufacturing capabilities in the United States. Roncadelle Operations S.r.l., an Italy-based company, specializes in providing vaccine and injectable drug delivery devices.
Major companies operating in the vaccine delivery devices market are Johnson & Johnson, Sanofi S.A., 3M Company, GlaxoSmithKline plc, Becton Dickinson and Company, INOVIO Pharmaceuticals Inc., Terumo Corporation, SCHOTT AG, Vaxxas Inc., PharmaJet Inc., Enesi Pharma Limited, NanoPass Technologies Ltd., Gerresheimer AG, West Pharmaceutical Services Inc., Nemera, SHL Medical AG, Portal Instruments Inc., ApiJect Systems Corp., Credence MedSystems Inc., Zosano Pharma Corporation
North America was the largest region in the vaccine delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the vaccine delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The vaccine delivery devices market consists of sales of jet injectors, auto-injectors, oral vaccine delivery, microneedle patches, transdermal patches, inhalers, and intradermal devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vaccine Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses vaccine delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for vaccine delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vaccine delivery devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.